Amgen Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones

2025.12.04 21:35

I'm PortAI, I can summarize articles.

Amgen Inc. shares fell 1.52% to $340.16 on Thursday, underperforming compared to competitors. The S&P 500 Index rose 0.11%, while the Dow Jones Industrial Average fell 0.07%. Amgen's stock ended a two-day winning streak and closed 1.80% below its 52-week high. Competitors' performances varied: Johnson & Johnson fell 1.39%, Pfizer rose 0.51%, and AbbVie fell 0.66%. Trading volume was 3.4 million, above the 50-day average of 2.5 million.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Amgen Inc. (AMGN) slipped 1.52% to $340.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.11% to 6,857.12 and the Dow Jones Industrial Average falling 0.07% to 47,850.94. The stock's fall snapped a two-day winning streak. Amgen Inc. closed 1.80% below its 52-week high of $346.38, which the company achieved on December 3rd. The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.39% to $202.48, Pfizer Inc. (PFE) rose 0.51% to $25.70, and AbbVie Inc. (ABBV) fell 0.66% to $228.71. Trading volume (3.4 M) eclipsed its 50-day average volume of 2.5 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-04-25 1635ET